For decades, cardiovascular risk assessment has often been reduced to a familiar panel of numbers: total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides. These remain important. In fact, current European and American guidance continues to regard LDL cholesterol and other apolipoprotein B containing lipoproteins as central, causal drivers of atherosclerotic cardiovascular disease. (Escardio) But cardiovascular disease is not caused by a single abnormal blood test. A person can have an apparently reassuring cholesterol result and still carry substantial cardiovascular risk

Wearable technology has come a long way from simply counting our steps. Today’s smart rings, watches, connected scales and glucose sensors can provide a much broader picture of everyday physiology. But with so many devices available, what do they actually tell us? A window into everyday health Different wearables measure different aspects of health. Smart rings such as Oura, Ultrahuman and RingConn focus particularly on sleep, heart rate, heart rate variability, temperature, activity and recovery. Their small size and lack of a

The modern longevity question is no longer simply, “How long can we live?” Increasingly, the more useful question is: “How can we identify important health risks early and support people to maintain health and function for as long as possible?” Longevity medicine is developing rapidly. Advances in genomics, biomarkers, wearable technology and data analysis are creating new opportunities to understand individual health risks. However, it is important to distinguish between what is already established in clinical practice and what remains an